Clinical Trial Update: Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical study of Tang Wang Prescription aimed at intervening in diabetic non-proliferative retinopathy is reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tang Wang Prescription

Snippet

Sponsor: Fengmei Lian | Conditions: Diabetic Non-proliferative Retinopathy, Type2 Diabetes | EARLY_Phase 1 | Status: UNKNOWN